Skip to main content
. 2016 Feb 15;222(1):41–59. doi: 10.1007/s00429-016-1199-8

Fig. 7.

Fig. 7

Reduction of Kir5.1 in oligodendrocytes and myelin in the absence of Kir4.1. Immunolocalization of Kir5.1 with myelin basic protein, MBP (A, B) and the oligodenrocyte marker APC/CC1 (CF), in brain tissue from wild-type Kir4.1+/+ mice (A, C, E) compared to Kir4.1−/− knock-out mice (B, D, F). Scale bars 20 μm. Western blot analysis of Kir5.1 from total lysates of optic nerve (G) and brain (H) from wild-type Kir4.1+/+ and Kir4.1−/− knock-out mice, and mean (±SEM) integrated density normalised against β-actin (I, n = 3, **p < 0.01; ***p < 0.001, one-tailed t test)

HHS Vulnerability Disclosure